Cancer-Causing Proteins Camp Lejeune NC

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

Hugh J Wallace
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialty
Hematology / Oncology

Data Provided by:
Russell Earle Burgess, MD
(252) 635-3977
PO Box 68
Pollocksville, NC
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1974
Hospital
Hospital: Onslow Memorial Hospital, Jacksonville, Nc
Group Practice: Ecu Physicians Brody School Of Medicine

Data Provided by:
Susan L Blackwel, MS
(919) 684-5621
25178 Morris Bldg Box 3198,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
James M Coghill, MD
(919) 966-4970
CB 7305 3009 Old Clinic Bldg,
Chapel Hill, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Kenneth Irvin Fink
(910) 772-9202
2131 S 17th St
Wilmington, NC
Specialty
Medical Oncology

Data Provided by:
John Chute
(919) 620-4467
Duke University Medical Ctr
Durham, NC
Specialty
Medical Oncology

Data Provided by:
Kamal Manubhai Bakri
(910) 609-6910
1638 Owen Dr
Fayetteville, NC
Specialty
Internal Medicine, Medical Oncology

Data Provided by:
James Ronald W Humbert, MD
(252) 816-4676
288 W Teaching Annex
Greenville, NC
Specialties
Oncology (Cancer), Pediatrics
Gender
Male
Education
Medical School: Centre Med Univ, Fac De Med, Geneve, Switzerland (Univ De Geneve)
Graduation Year: 1964

Data Provided by:
Glenn J Lesser
(336) 716-2255
Medical Center Blvd
Winston Salem, NC
Specialty
Internal Medicine, Medical Oncology

Data Provided by:
Sascha A Tuchman
(919) 684-8111
2100 Erwin Rd
Durham, NC
Specialty
Hematology

Data Provided by:
Data Provided by:

Cancer-Causing Proteins

Provided By:

Scientists are closer to understanding how a recently approved class of antibiotics may work against cancer.

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

The researchers also found that thiazoles may inhibit proteasomes, a molecular complex within cells that disposes of old proteins marked for destruction. Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.

The new research, which appears in the online journal PLoS ONE, points to the possible anti-cancer use of thiazoles in the future. In a university news release, study author Andrei Gartel, an associate professor of molecular genetics, said that by using thiazole antibiotics in combination with well-known proteasome inhibitors, "we may see a synergy that allows us to markedly reduce the dose of any one of these drugs and still effectively kill the cancer cells."

More information

Read more about cancer treatments at the U.S. National Cancer Institute.

SOURCE: University of Illinois at Chicago, news release, Aug. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com